Association of cytomegalovirus genotype with graft rejection after liver transplantation

Transplantation

Volumn 66, Issue 12, 1998, Pages 1627-1631

  Rosen, Hugo R ^a,b   Corless, Christopher L ^a   Rabkin, John ^a   Chou, Sunwen ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; GANCICLOVIR; METHYLPREDNISOLONE SODIUM SUCCINATE; OKT 3; TACROLIMUS; THYMOCYTE ANTIBODY; VIRUS GLYCOPROTEIN;

ADULT; ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; GENOTYPE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHYLAXIS; SURVIVAL RATE; TREATMENT OUTCOME; VIRUS ISOLATION;

ADULT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GENOTYPE; GRAFT REJECTION; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; VIRAL ENVELOPE PROTEINS; VIREMIA;

EID: 0032573677     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199812270-00010     Document Type: Article

References (31)

1. Patel R, Snydman DR, Rubin RH, et al. Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation 1996; 61: 1279.
2. Soderberg-Naucler C, Fish KN, Nelson JA. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997; 91: 119.
3. Everett JP, Hershberger RE, Norman DJ, et al. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant 1992; 11: S133.
4. Keenan RJ, Lega ME, Dummer JS, et al. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991; 51: 433.
5. Yilmaz S, Koskinen PK, Kallio E, Bruggeman CA, Hayry PJ, Lemstrom KB. Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression. Kidney Int 1996; 50: 526.
6. Lautenschlager I, Hockerstedt K, Jalanko H, et al. Persistent cytomegalovirus in liver allografts with chronic rejection. Hepatology 1997; 25: 190.
7. Koskinen P, Lemstrom K, Bruggeman C, Lautenschlager I, Hayry P. Acute cytomegalovirus infection induces a subendothelial inflammation in the allograft vascular wall: a possible linkage with enhanced allograft arteriosclerosis. Am J Pathol 1994; 144: 41.
8. Kowalik TF, Wing B, Haskill JS, Azizkhan JC, Baldwin AS, Huang ES. Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Immunology 1993; 78: 405.
9. Rubin RH. Cytomegalovirus disease and allograft loss after organ transplantation. Clin Infect Dis 1998; 26; 871.
10. Chou S, Dennison KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1991; 163: 1229.
11. Rasmussen L, Hong C, Zipeto D, Morris S, et al. Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis 1997; 175: 179.
12. Shepp DH, Match ME, Ashraf AB, Lipson SM, Millan C, Pergolizzi R. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 1996; 174(1): 184.
13. International Working Party. Terminology for hepatic allograft rejection. Hepatology 1995; 22: 648.
14. Gleaves CA, Smith TF, Shuster EA, Pearson GR. Comparison of standard tube and shell vial culture techniques for the detection of cytomegalovirus in clinical specimens. J Clin Microbiol 1985; 21: 217.
15. Chou S. Comparative analysis of sequence variation in gp116 and gp55 components of glycoprotein B of human cytomegalovirus. Virology 1992; 188: 388.
16. Fries BC, Chou S, Boeckh M, Torok-Storb B. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 1994; 169: 769.
17. Paya CV, Herman PE, Wiesner RH, et al. Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis 1989; 160: 752.
18. Drouet E, Colimon R, Michelson S, et al. Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation. J Clin Microbiol 1995; 33: 389.
19. Rosen HR, Chou S, Corless CL, et al. Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C. Transplantation 1997; 64: 721.
20. Stratta RJ, Shaeffer MS, Markin RS, et al. Clinical patterns of cytomegalovirus disease after liver transplantation. Arch Surg 1989; 124: 1443.
21. Falagas ME, Snydman DR, Griffith J, et al. Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. Ann Intern Med 1997; 126: 275.
22. De Otero J, Gavalda J, Murio E, et al. Cytomegalovirus disease is a risk factor for graft loss and death after orthotopic liver transplantation. Clin Infect Dis 1998; 26: 865.
23. Bankier AT, Beck S, Bohni R, et al. The DNA sequence of the human cytomegalovirus genome. DNA Seq 1991; 2: 1.
24. Chou S. Neutralizing antibody responses to reinfecting strains of cytomegalovirus in transplant recipients. J Infect Dis 1989; 160: 16.
25. Utz U, Britt W, Vugler L, Mach M. Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus. J Virol 1989; 63: 1995.
26. Rasmussen L, Matkin C, Spaete R, Pachl C, Merigan TC. Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans. J Infect Dis 1991; 164: 835.
27. Navarro D, Paz P, Tugizov S, Topp K, La Vail J, Pereira L. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 1993; 197: 143.
28. Torok-Storb B, Boeckh M, Hoy C, Leisenring W, Myerson D, Gooley T. Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 1997; 90(5): 2097.
29. Hebart H, Grief M, Krause H, et al. Interstrain variation of immediate early DNA sequences and glycoprotein B genotypes in cytomegalovirus clinical isolates. Med Microbiol Immunol (Berl) 1997; 186: 135.
30. Woo PC, Lo CY, Lo SK, et al. Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Clin Diagn Lab Immunol 1997; 4: 515.
31. Vogelberg C, Meyer-Konig U, Hufert FT, Kirste G, von Laer D. Human cytomegalovirus glycoprotein B genotypes in renal transplant recipients. J Med Virol 1996; 50: 31.